• Info
  • Insider Ownership

Insider Trading & Ownership of Rick E. Winningham

Location
South San Francisco, CA
Summary
The estimated net worth of Rick E. Winningham is at least $34,670,095 dollars as of 03 Apr 2026. Rick E. Winningham is the CHIEF EXECUTIVE OFFICER, Director of Theravance Biopharma, Inc. and owns shares of Theravance Biopharma, Inc. (TBPH) stock worth about $33.06M. Rick E. Winningham is the Director of Jazz Pharmaceuticals plc and owns shares of Jazz Pharmaceuticals plc (JAZZ) stock worth about $1.61M.
Signature
/s/ Brett A Grimaud, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Rick E. Winningham and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sponsored

Quick Takeaways

  • Rick E. Winningham has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $34,670,095.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Theravance Biopharma, Inc. ($33,061,710).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Rick E. Winningham

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TBPH Theravance Biopharma, Inc. CHIEF EXECUTIVE OFFICER, Director $33,061,710 01 Apr 2026
JAZZ Jazz Pharmaceuticals plc Director $1,608,385 -$994,728 -38% 18 Nov 2025

Insider Transactions Reported by Rick E. Winningham:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.